Literature DB >> 7834800

The DNA binding activity of the liver transcription factors LFB1 (HNF1) and HNF4 varies coordinately in rat hepatocellular carcinoma.

H Stumpf1, S Senkel, H M Rabes, G U Ryffel.   

Abstract

As renal cell carcinomas are characterized by the disappearance of the transcription factor LFB1, which is known to be primarily involved in gene regulation in the liver, we have measured the presence of LFB1 in rat hepatocellular carcinomas induced by diethylnitrosamine. The level of LFB1 binding activity in adenoid-cystic as well as trabecular tumours shows some variation and may either be lower or higher than in the non-tumorous tissue. The amount of LFB1 binding activity correlates with the binding activity of HNF4, a transcription factor reported to stimulate LFB1 expression. As the levels of LFB1 and HNF4 binding activity differ extensively in various hepatocellular carcinomas, it is unlikely that these transcription factors play a general role in hepatocarcinogenesis. This is in contrast to renal carcinogenesis where a dramatic loss of LFB1 is a consistent feature.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7834800     DOI: 10.1093/carcin/16.1.143

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

Review 1.  Liver enriched transcription factors and differentiation of hepatocellular carcinoma.

Authors:  Y Hayashi; W Wang; T Ninomiya; H Nagano; K Ohta; H Itoh
Journal:  Mol Pathol       Date:  1999-02

2.  Inhibitor of the tissue-specific transcription factor HNF4, a potential regulator in early Xenopus development.

Authors:  G Peiler; B Böckmann; H Nakhei; G U Ryffel
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types.

Authors:  H Nakhei; A Lingott; I Lemm; G U Ryffel
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.